The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen · Kit
1 marketed package NDCs · 1 active manufacturer
Common questions
- Is Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen in shortage right now?
- No. FDA does not currently list Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen?
- 1 company has marketed Haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.